Product NDC: | 53014-548 |
Proprietary Name: | Tussionex Pennkinetic |
Non Proprietary Name: | hydrocodone polistirex and chlorpheniramine polistirex |
Active Ingredient(s): | 8; 10 mg/5mL; mg/5mL & nbsp; hydrocodone polistirex and chlorpheniramine polistirex |
Administration Route(s): | ORAL |
Dosage Form(s): | SUSPENSION, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 53014-548 |
Labeler Name: | UCB Manufacturing Inc |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA019111 |
Marketing Category: | NDA |
Start Marketing Date: | 19871231 |
Package NDC: | 53014-548-01 |
Package Description: | 1 BOTTLE, GLASS in 1 CARTON (53014-548-01) > 115 mL in 1 BOTTLE, GLASS |
NDC Code | 53014-548-01 |
Proprietary Name | Tussionex Pennkinetic |
Package Description | 1 BOTTLE, GLASS in 1 CARTON (53014-548-01) > 115 mL in 1 BOTTLE, GLASS |
Product NDC | 53014-548 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | hydrocodone polistirex and chlorpheniramine polistirex |
Dosage Form Name | SUSPENSION, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19871231 |
Marketing Category Name | NDA |
Labeler Name | UCB Manufacturing Inc |
Substance Name | CHLORPHENIRAMINE; HYDROCODONE |
Strength Number | 8; 10 |
Strength Unit | mg/5mL; mg/5mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC],Opioid Agonist [EPC],Opioid Agonists [MoA] |